Jenburkt Pharmaceuticals Ltd. - Research Center
524731 JENBURPH Group (X) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 141.97 | 136.75 | 123.98 | 109.29 | 118.89 |
| Operating profit | 33.12 | 30.37 | 27.26 | 19.84 | 19.74 |
| Interest | 0.27 | 0.37 | 0.43 | 0.47 | 0.53 |
| Gross profit | 37.52 | 35.12 | 31.77 | 23.68 | 23.44 |
| EPS (Rs) | 58.86 | 55.76 | 48.58 | 35.96 | 32.40 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 4.67 | 5.12 | 4.95 | 4.31 | 4.22 |
| Stock adjustment | -0.39 | 1.34 | -2.28 | 3.18 | -0.49 |
| Raw material | 8.39 | 11.12 | 11.74 | 6.78 | 9.65 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 42.49 | 38.81 | 36.49 | 32.38 | 36.51 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 58.36 | 55.12 | 50.78 | 47.11 | 53.47 |
| Provisions made | - | - | - | - | - |
| Depreciation | 2.34 | 2.26 | 1.90 | 2.04 | 2.30 |
| Taxation | 9.20 | 8.26 | 7.57 | 5.14 | 6.27 |
| Net profit / loss | 25.98 | 24.61 | 22.30 | 16.50 | 14.87 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 4.41 | 4.41 | 4.59 | 4.59 | 4.59 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 23.33 | 22.21 | 21.98 | 18.15 | 16.61 |
| GPM (%) | 25.58 | 24.76 | 24.64 | 20.84 | 19.04 |
| NPM (%) | 17.72 | 17.34 | 17.29 | 14.53 | 12.08 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis